Peter Sleight

73.1k total citations · 10 hit papers
387 papers, 27.9k citations indexed

About

Peter Sleight is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Complementary and alternative medicine. According to data from OpenAlex, Peter Sleight has authored 387 papers receiving a total of 27.9k indexed citations (citations by other indexed papers that have themselves been cited), including 281 papers in Cardiology and Cardiovascular Medicine, 69 papers in Surgery and 46 papers in Complementary and alternative medicine. Recurrent topics in Peter Sleight's work include Heart Rate Variability and Autonomic Control (134 papers), Blood Pressure and Hypertension Studies (93 papers) and Cardiovascular and exercise physiology (46 papers). Peter Sleight is often cited by papers focused on Heart Rate Variability and Autonomic Control (134 papers), Blood Pressure and Hypertension Studies (93 papers) and Cardiovascular and exercise physiology (46 papers). Peter Sleight collaborates with scholars based in United Kingdom, Italy and Canada. Peter Sleight's co-authors include Salim Yusuf, Rory Collins, Richard Peto, Sarah Parish, Colin Baigent, John A. Lewis, Thomas G. Pickering, George Pickering, Harley S. Smyth and B. Gribbin and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Peter Sleight

377 papers receiving 26.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Beta blockade during and after myocardial infarction: An overview of the randomized trials

1985 2.4k citations Salim Yusuf, Richard Peto et al. profile →
Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

1988 2.1k citations Peter Sleight, Sarah Parish et al. profile →
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials

2015 1.0k citations Peter Sleight et al. The Lancet profile →
Reflex Regulation of Arterial Pressure during Sleep in Man

1969 1.0k citations Peter Sleight et al. profile →
Effect of Age and High Blood Pressure on Barorefiex Sensitivity in Man

1971 832 citations Peter Sleight et al. profile →
MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial

2002 781 citations R Collins, Jane Armitage et al. The Lancet profile →
Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions

2004 749 citations Sarah Parish, Peter Sleight et al. The Lancet profile →
Changes in autonomic regulation induced by physical training in mild hypertension.

1988 617 citations Peter Sleight et al. profile →
Diminished Baroreflex Sensitivity in High Blood Pressure

1969 457 citations A. J. Honour, Peter Sleight et al. Circulation profile →
Urinary Sodium and Potassium Excretion and Risk of Cardiovascular Events

2011 425 citations Salim Yusuf, Andrew Mente et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Sleight United Kingdom	82	19.0k	6.4k	3.6k	2.8k	2.6k	387	27.9k
Thomas G. Pickering United States	89	24.2k 1.3×	6.4k 1.0×	2.6k 0.7×	1.8k 0.6×	2.9k 1.1×	429	36.6k
Jay N. Cohn United States	97	35.0k 1.8×	7.0k 1.1×	4.0k 1.1×	2.8k 1.0×	3.2k 1.2×	544	43.0k
Michael S. Lauer United States	77	17.9k 0.9×	4.5k 0.7×	3.8k 1.0×	1.8k 0.7×	1.1k 0.4×	295	25.8k
Gianfranco Parati Italy	101	30.5k 1.6×	8.5k 1.3×	3.2k 0.9×	4.0k 1.5×	3.1k 1.2×	1.0k	42.1k
Guıdo Grassı Italy	79	23.8k 1.3×	4.9k 0.8×	2.3k 0.6×	1.1k 0.4×	5.3k 2.0×	703	32.3k
Robert Fagard Belgium	75	23.9k 1.3×	4.5k 0.7×	4.3k 1.2×	643 0.2×	5.5k 2.1×	489	33.0k
Alberto Zanchetti Italy	90	34.4k 1.8×	7.1k 1.1×	1.6k 0.5×	842 0.3×	10.5k 4.1×	836	45.4k
Dárrel P. Francis United Kingdom	71	14.3k 0.8×	4.5k 0.7×	2.4k 0.7×	1.6k 0.6×	1.0k 0.4×	401	19.8k
Henry Krum Australia	94	27.8k 1.5×	5.5k 0.9×	1.3k 0.4×	1.8k 0.6×	6.8k 2.6×	566	36.9k
Luigi Tavazzi Italy	105	39.9k 2.1×	7.2k 1.1×	1.7k 0.5×	2.4k 0.9×	2.3k 0.9×	579	47.5k

Countries citing papers authored by Peter Sleight

Since Specialization

Citations

This map shows the geographic impact of Peter Sleight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Sleight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Sleight more than expected).

Fields of papers citing papers by Peter Sleight

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Sleight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Sleight. The network helps show where Peter Sleight may publish in the future.

Co-authorship network of co-authors of Peter Sleight

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Sleight. A scholar is included among the top collaborators of Peter Sleight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Sleight. Peter Sleight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Foulquier, Sébastien, Michael Böhm, Roland E. Schmieder, et al.. (2014). Impact of telmisartan on cardiovascular outcome in hypertensive patients at high risk. Journal of Hypertension. 32(6). 1334–1341. 13 indexed citations

Dehghan, Mahshid, Andrew Mente, Koon Teo, et al.. (2012). Relationship Between Healthy Diet and Risk of Cardiovascular Disease Among Patients on Drug Therapies for Secondary Prevention. Circulation. 126(23). 2705–2712. 122 indexed citations

Mancia, Giuseppe, Helmut Schumacher, Josep Redón, et al.. (2011). Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET). Circulation. 124(16). 1727–1736. 115 indexed citations

Böhm, Michael, Magnus Baumhäkel, Koon Teo, et al.. (2010). Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both. Circulation. 121(12). 1439–1446. 132 indexed citations

Cukierman‐Yaffe, Tali, Hertzel C. Gerstein, Craig S. Anderson, et al.. (2009). Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: Results from the ONTARGET/TRANSCEND Research Programme. Diabetes Research and Clinical Practice. 83(3). 387–393. 21 indexed citations

Pinna, Gian Domenico, Roberto Maestri, D. C. Andrews, et al.. (2007). Home telemonitoring of vital signs and cardiorespiratory signals in heart failure patients: System architecture and feasibility of the HHH model. International Journal of Cardiology. 120(3). 371–379. 29 indexed citations

Pinna, Gian Domenico, Roberto Maestri, Andrea Mortara, et al.. (2006). Nocturnal periodic breathing is an independent predictor of cardiac death and multiple hospital admissions in Heart failure. Oxford University Research Archive (ORA) (University of Oxford). 33. 837–840. 11 indexed citations

Sleight, Peter. (2006). Benefits, challenges, and registerability of the polypill. European Heart Journal. 27(14). 1651–1656. 74 indexed citations

Mortara, Andrea, Gian Domenico Pinna, Soccorso Capomolla, et al.. (2005). A multi-country randomised trial of the role of a new telemonitoring system in CHF: the HHH Study (Home or Hospital in Heart Failure). Preliminary data. European Heart Journal. 26. 20–21. 3 indexed citations

10.

Teo, Koon, Salim Yusuf, Peter Sleight, et al.. (2004). Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination, in high risk patients: The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telm. American Heart Journal. 148. 2 indexed citations

11.

Collins, R, et al.. (2002). MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial. The Lancet. 360(9326). 23–33. 781 indexed citations breakdown →

12.

Kjeldsen, Sverre E., Ingrid Os, Csaba Farsang, et al.. (2000). European Society of Hypertension Scientific Newsletter, Update on Hypertension Management. Journal of Hypertension. 18(9). 1345–1346. 10 indexed citations

13.

Sleight, Peter. (1994). What Happened to Intravenous Atenolol in Acute Myocardial Infarction?. Cardiology. 85(1). 13–17. 1 indexed citations

14.

Schlant, Robert C., R.A. O'Rourke, D Collen, et al.. (1994). Reperfusion in acute myocardial infarction. RePub (Erasmus University, Rotterdam). 90. 2091–2102. 6 indexed citations

15.

Zanchetti, Alberto, John Chalmers, Pierre Corvol, et al.. (1989). 1989 Guidelines for the management of mild hypertension: Memorandum from a WHO/ISH meeting. Bulletin of the World Health Organization. 67(5). 493–498. 57 indexed citations

16.

Yusuf, Salim, P Rossi, Richard Peto, et al.. (1983). REDUCTION IN INFARCT SIZE, MORBIDITY AND SHORT-TERM MORTALITY BY EARLY INTRAVENOUS BETABLOCKADE. Journal of the American College of Cardiology. 1. 676–676. 5 indexed citations

17.

Raine, June, Mark Palazzo, John Kerr, & Peter Sleight. (1981). Near-fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane.. BMJ. 282(6263). 548–549. 69 indexed citations

18.

Littler, W A, et al.. (1975). Sleep and blood pressure.. BMJ. 3(5979). 346–348. 112 indexed citations

19.

Littler, W A, A. J. Honour, & Peter Sleight. (1973). Direct Arterial Pressure and Electrocardiogram during Motor Car Driving. BMJ. 2(5861). 273–277. 24 indexed citations

20.

Harris, A, Peter Sleight, & C. E. Drew. (1965). THE DIAGNOSIS AND TREATMENT OF AORTIC STENOSIS COMPLICATED BY HEART BLOCK. Heart. 27(4). 560–565. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact